- Home
- MTN vs TECH Comparison
MTN vs TECH Comparison
Compare MTN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTN
- TECH
- Stock Information
- Founded
- MTN 1997
- TECH 1976
- Country
- MTN United States
- TECH United States
- Employees
- MTN N/A
- TECH N/A
- Industry
- MTN Services-Misc. Amusement & Recreation
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTN Consumer Discretionary
- TECH Health Care
- Exchange
- MTN Nasdaq
- TECH Nasdaq
- Market Cap
- MTN N/A
- TECH 8.0B
- IPO Year
- MTN 1997
- TECH 1989
- Fundamental
- Price
- MTN $138.43
- TECH $48.10
- Analyst Decision
- MTN Hold
- TECH Buy
- Analyst Count
- MTN 9
- TECH 9
- Target Price
- MTN $193.33
- TECH $81.25
- AVG Volume (30 Days)
- MTN 695.0K
- TECH 2.2M
- Earning Date
- MTN 06-05-2025
- TECH 05-07-2025
- Dividend Yield
- MTN 6.42%
- TECH 0.63%
- EPS Growth
- MTN 10.73
- TECH N/A
- EPS
- MTN 6.89
- TECH 0.98
- Revenue
- MTN $2,946,168,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- MTN $4.74
- TECH $8.19
- Revenue Next Year
- MTN $4.20
- TECH $8.85
- P/E Ratio
- MTN $20.09
- TECH $49.09
- Revenue Growth
- MTN 3.57
- TECH 4.46
- 52 Week Low
- MTN $129.85
- TECH $46.44
- 52 Week High
- MTN $219.84
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- MTN 37.58
- TECH 33.97
- Support Level
- MTN $129.85
- TECH $46.44
- Resistance Level
- MTN $145.23
- TECH $53.00
- Average True Range (ATR)
- MTN 6.72
- TECH 3.30
- MACD
- MTN -0.98
- TECH -0.27
- Stochastic Oscillator
- MTN 25.73
- TECH 13.00
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.